Alnylam Pharmaceuticals
ALNY
#649
Rank
NZ$52.63 B
Marketcap
$408.06
Share price
-7.14%
Change (1 day)
44.14%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Alnylam Pharmaceuticals (ALNY) - Total assets

Total assets on the balance sheet as of September 2024 : NZ$7.16 Billion

According to Alnylam Pharmaceuticals 's latest financial reports the company's total assets are NZ$7.16 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Alnylam Pharmaceuticals - Total assets on balance sheet (from 2003 to 2024)

Total assets by year

Year Total assets Change
2023-12-31NZ$6.05 B8.42%
2022-12-31NZ$5.58 B4.72%
2021-12-31NZ$5.33 B12.96%
2020-12-31NZ$4.72 B32.77%
2019-12-31NZ$3.55 B51.48%
2018-12-31NZ$2.34 B-16.41%
2017-12-31NZ$2.80 B54.06%
2016-12-31NZ$1.82 B-10.01%
2015-12-31NZ$2.02 B47.02%
2014-12-31NZ$1.37 B169.25%
2013-12-31NZ$0.51 B46.42%
2012-12-31NZ$0.34 B-3.24%
2011-12-31NZ$0.36 B-29.14%
2010-12-31NZ$0.50 B-23.09%
2009-12-31NZ$0.66 B-30.66%
2008-12-31NZ$0.95 B48.27%
2007-12-31NZ$0.64 B89.23%
2006-12-31NZ$0.34 B136.76%
2005-12-31NZ$0.14 B55.31%
2004-12-31NZ$92.64 M71.17%
2003-12-31NZ$54.12 M75.81%
2002-12-31NZ$30.78 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
NZ$1.50 B-78.98%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$63.79 B 790.41%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$6.13 B-14.39%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$3.37 B-52.92%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.17 B-97.52%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$176.38 B 2,361.90%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
NZ$236.99 B 3,207.82%๐Ÿ‡ซ๐Ÿ‡ท France
NZ$71.14 B 893.05%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel